Infinium Global Research Veternary Therapeutics - IGR | Page 4

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/771
Based on end user segment veterinary hospital segment is the largest segment by covering
maximum market, and expected to retain its dominance. Among the geographies North America
dominated the global market and it is anticipated to retain its dominance by accounting largest
market shares during forecast period of 2017 to 2023. The report covers the analysis of global
as well as regional markets of the Veterinary Therapeutics market.
The report provides insights into the market using analytical tools such as Porter’s five forces
analysis and value chain analysis of Veterinary Therapeutics. Moreover, the study highlights
current market trends and provides forecast from 2017 to 2023. We also have highlighted future
trends in the Veterinary Therapeutics that will impact the demand during the forecast period.
The companies covered in the report include Boehringer Ingelheim Vetmedica, Bayer Animal
Health, Inc., Dechra Animal Health, Ceva Sante Animale, Elanco Animal Health, Merck Animal
Health, Virbac S.A., Merial Animal Health, Zoetis, Inc., and Vetoquinol S.A.
Infinium Global Research